El Dipòsit Digital ha actualitzat el programari. Qualsevol incidència que trobeu si us plau contacteu amb dipositdigital@ub.edu.

 

Documents de treball / Informes (ISGlobal)

URI permanent per a aquesta col·leccióhttps://diposit.ub.edu/handle/2445/173778

 Estadístiques

Examinar

Enviaments recents

Mostrant 1 - 4 de 4
  • Miniatura
    logoOpenAccessInforme
    BA.5 Omicron subvariant in Catalonia: Current impact and recommendations for booster vaccination strategies
    (Institut de Salut Global de Barcelona (ISGlobal), 2022-07-18) Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC); Blanco Arbués, Julià; Sarukhan, Adelaida; Díez Antón, Juana, 1962-; Bassat Orellana, Quique; Campins Martí, Magda; Güerri Fernández, Robert; Brotons, Carlos; Sans Corrales, Mireia; Miró Meda, José M. (José María), 1956-; Sanjosé Llongueras, Silvia de
    Circulation of the Omicron BA.5 subvariant has led to a considerable increase in cases and also in hospitalisations (but not severe cases or deaths) in recent weeks in Catalonia, the rest of Spain and many other countries. Based on scientific evidence and the current epidemiological situation, the Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC) has conducted an analysis of the impact of the BA-5 subvariant in Catalonia and, with the support of the COVID-19 Scientific Advisory Committee (CCAC) attached to the Department of Health of the Government of Catalonia, has issued a series of recommendations for booster vaccination strategies.
  • Miniatura
    logoOpenAccessInforme
    Post-Acute COVID Syndrome (PACS): Definition, Impact and Management
    (Institut de Salut Global de Barcelona (ISGlobal), 2021-06-11) Lledó. Gema; Sellarés Torres, Jacobo; Brotons, Carlos; Sans Corrales, Mireia; Díez Antón, Juana, 1962-; Blanco Arbués, Julià; Bassat Orellana, Quique; Sarukhan, Adelaida; Campins Martí, Magda; Güerri Fernández, Robert; Miró Meda, José M. (José María), 1956-; Sanjosé Llongueras, Silvia de
    A variety of studies suggest that up to 10-15% of all patients with COVID-19 may present persistent symptomatology weeks or even months after the original infection. Given the accumulated burden of COVID-19 in Catalonia, Spain, we speculate that over 90,000 patients could have been or are currently affected by persistent symptoms or sequelae. The Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC) presents its third report where they propose a clear set of case definitions of Post-Acute COVID syndrome (PACS) and its sub-categories and recommend a comprehensive medical examination to characterise the clinical features and complications when assessing PACS.
  • Miniatura
    logoOpenAccessInforme
    What do we know about Immunity to SARS-CoV-2? Implications for Public Health Policies
    (Institut de Salut Global de Barcelona (ISGlobal), 2021-02-24) Blanco Arbués, Julià; Sarukhan, Adelaida; Díez Antón, Juana, 1962-; Bassat Orellana, Quique; Campins Martí, Magda; Güerri Fernández, Robert; Brotons, Carlos; Sans Corrales, Mireia; Miró Meda, José M. (José María), 1956-; Sanjosé Llongueras, Silvia de
    As the COVID-19 pandemic progresses, so does our knowledge of the magnitude, type and durability of the immune response to SARS-CoV-2 as a result of natural infection or vaccination. This information is crucial since it will largely define the strategies we need to implement in order to protect individuals and populations. With this in mind, the GCMSC presents its second report, where they review the current knowledge on immunity to SARS-CoV-2 and the implications in terms of public health policies.
  • Miniatura
    logoOpenAccessInforme
    COVID-19 Immunisation Strategy: Priority Populations
    (Institut de Salut Global de Barcelona (ISGlobal), 2020-11-23) Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC); Sanjosé Llongueras, Silvia de; Miró Meda, José M. (José María), 1956-; Bassat Orellana, Quique; Campins Martí, Magda; Güerri Fernández, Robert; Brotons, Carlos; Díez Antón, Juana, 1962-; Blanco Arbués, Julià; Sans Corrales, Mireia; Rubio, Olga; Sarukhan, Adelaida
    With a limited initial supply of COVID-19 vaccines doses and an expected delay for the universal vaccination of those eligible to receive it, it is relevant to analyse how best to prioritise the first available doses to achieve the greatest impact, both in terms of protecting individuals and minimising community transmission. Ethical issues are key in guiding a fair distribution. Different scenarios on vaccine implementation are summarised in this report. After a critical review of the documents and considering that these criteria are applied to Spanish citizens, the members of theGCMSC establish a priority vaccination list based on ethical principles and adapted to our countr